100 related articles for article (PubMed ID: 33445307)
21. Signaling pathway activation drift during aging: Hutchinson-Gilford Progeria Syndrome fibroblasts are comparable to normal middle-age and old-age cells.
Aliper AM; Csoka AB; Buzdin A; Jetka T; Roumiantsev S; Moskalev A; Zhavoronkov A
Aging (Albany NY); 2015 Jan; 7(1):26-37. PubMed ID: 25587796
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic involvement in Hutchinson-Gilford progeria syndrome: a mini-review.
Arancio W; Pizzolanti G; Genovese SI; Pitrone M; Giordano C
Gerontology; 2014; 60(3):197-203. PubMed ID: 24603298
[TBL] [Abstract][Full Text] [Related]
23. Imbalanced nucleocytoskeletal connections create common polarity defects in progeria and physiological aging.
Chang W; Wang Y; Luxton GWG; Östlund C; Worman HJ; Gundersen GG
Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3578-3583. PubMed ID: 30808750
[TBL] [Abstract][Full Text] [Related]
24. Expression of the Hutchinson-Gilford Progeria Mutation Leads to Aberrant Dentin Formation.
Choi H; Kim TH; Jeong JK; Strandgren C; Eriksson M; Cho ES
Sci Rep; 2018 Oct; 8(1):15368. PubMed ID: 30337599
[TBL] [Abstract][Full Text] [Related]
25. Progeria of stem cells: stem cell exhaustion in Hutchinson-Gilford progeria syndrome.
Halaschek-Wiener J; Brooks-Wilson A
J Gerontol A Biol Sci Med Sci; 2007 Jan; 62(1):3-8. PubMed ID: 17301031
[TBL] [Abstract][Full Text] [Related]
26. Differential stem cell aging kinetics in Hutchinson-Gilford progeria syndrome and Werner syndrome.
Wu Z; Zhang W; Song M; Wang W; Wei G; Li W; Lei J; Huang Y; Sang Y; Chan P; Chen C; Qu J; Suzuki K; Belmonte JCI; Liu GH
Protein Cell; 2018 Apr; 9(4):333-350. PubMed ID: 29476423
[TBL] [Abstract][Full Text] [Related]
27. Farnesyltransferase inhibitor and rapamycin correct aberrant genome organisation and decrease DNA damage respectively, in Hutchinson-Gilford progeria syndrome fibroblasts.
Bikkul MU; Clements CS; Godwin LS; Goldberg MW; Kill IR; Bridger JM
Biogerontology; 2018 Dec; 19(6):579-602. PubMed ID: 29907918
[TBL] [Abstract][Full Text] [Related]
28. Towards a Drosophila model of Hutchinson-Gilford progeria syndrome.
Beard GS; Bridger JM; Kill IR; Tree DR
Biochem Soc Trans; 2008 Dec; 36(Pt 6):1389-92. PubMed ID: 19021561
[TBL] [Abstract][Full Text] [Related]
29. Hutchinson-Gilford Progeria Syndrome: A premature aging disease caused by LMNA gene mutations.
Gonzalo S; Kreienkamp R; Askjaer P
Ageing Res Rev; 2017 Jan; 33():18-29. PubMed ID: 27374873
[TBL] [Abstract][Full Text] [Related]
30. Progerin impairs vascular smooth muscle cell growth via the DNA damage response pathway.
Kinoshita D; Nagasawa A; Shimizu I; Ito TK; Yoshida Y; Tsuchida M; Iwama A; Hayano T; Minamino T
Oncotarget; 2017 May; 8(21):34045-34056. PubMed ID: 28423660
[TBL] [Abstract][Full Text] [Related]
31. Progerin, the protein responsible for the Hutchinson-Gilford progeria syndrome, increases the unrepaired DNA damages following exposure to ionizing radiation.
Noda A; Mishima S; Hirai Y; Hamasaki K; Landes RD; Mitani H; Haga K; Kiyono T; Nakamura N; Kodama Y
Genes Environ; 2015; 37():13. PubMed ID: 27350809
[TBL] [Abstract][Full Text] [Related]
32. Progerin accelerates atherosclerosis by inducing endoplasmic reticulum stress in vascular smooth muscle cells.
Hamczyk MR; Villa-Bellosta R; Quesada V; Gonzalo P; Vidak S; Nevado RM; Andrés-Manzano MJ; Misteli T; López-Otín C; Andrés V
EMBO Mol Med; 2019 Apr; 11(4):. PubMed ID: 30862662
[TBL] [Abstract][Full Text] [Related]
33. Model of human aging: recent findings on Werner's and Hutchinson-Gilford progeria syndromes.
Ding SL; Shen CY
Clin Interv Aging; 2008; 3(3):431-44. PubMed ID: 18982914
[TBL] [Abstract][Full Text] [Related]
34. Progerin impairs chromosome maintenance by depleting CENP-F from metaphase kinetochores in Hutchinson-Gilford progeria fibroblasts.
Eisch V; Lu X; Gabriel D; Djabali K
Oncotarget; 2016 Apr; 7(17):24700-18. PubMed ID: 27015553
[TBL] [Abstract][Full Text] [Related]
35. Hutchinson-Gilford progeria syndrome through the lens of transcription.
Prokocimer M; Barkan R; Gruenbaum Y
Aging Cell; 2013 Aug; 12(4):533-43. PubMed ID: 23496208
[TBL] [Abstract][Full Text] [Related]
36. Lysophosphatidic acid receptor LPA
Chen WM; Chiang JC; Lin YC; Lin YN; Chuang PY; Chang YC; Chen CC; Wu KY; Hsieh JC; Chen SK; Huang WP; Chen BPC; Lee H
Aging Cell; 2020 Jan; 19(1):e13064. PubMed ID: 31714004
[TBL] [Abstract][Full Text] [Related]
37. Aging in the Cardiovascular System: Lessons from Hutchinson-Gilford Progeria Syndrome.
Hamczyk MR; del Campo L; Andrés V
Annu Rev Physiol; 2018 Feb; 80():27-48. PubMed ID: 28934587
[TBL] [Abstract][Full Text] [Related]
38. Hutchinson-Gilford progeria syndrome alters nuclear shape and reduces cell motility in three dimensional model substrates.
Booth-Gauthier EA; Du V; Ghibaudo M; Rape AD; Dahl KN; Ladoux B
Integr Biol (Camb); 2013 Mar; 5(3):569-77. PubMed ID: 23370891
[TBL] [Abstract][Full Text] [Related]
39. Rescue of heterochromatin organization in Hutchinson-Gilford progeria by drug treatment.
Columbaro M; Capanni C; Mattioli E; Novelli G; Parnaik VK; Squarzoni S; Maraldi NM; Lattanzi G
Cell Mol Life Sci; 2005 Nov; 62(22):2669-78. PubMed ID: 16261260
[TBL] [Abstract][Full Text] [Related]
40. Progerin reduces LAP2α-telomere association in Hutchinson-Gilford progeria.
Chojnowski A; Ong PF; Wong ES; Lim JS; Mutalif RA; Navasankari R; Dutta B; Yang H; Liow YY; Sze SK; Boudier T; Wright GD; Colman A; Burke B; Stewart CL; Dreesen O
Elife; 2015 Aug; 4():. PubMed ID: 26312502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
